How Should Clinicians Select Between Co2 Laser Systems And Erbium Laser Systems When Treating Benign Facial Skin Lesions? Key Factors Include Vascularity, Depth, And Thermal Control.

Choose based on vascularity, depth, and the amount of thermal control required. CO₂ lasers are generally preferable for vascular, thick, or hyperplastic benign lesions because they provide strong coagulation and hemostasis during ablation. Er:YAG lasers are better suited to superficial or less vascular lesions when precise layer-by-layer removal and minimal thermal injury are the priorities.

The central decision is not which laser is universally superior, but whether the lesion requires coagulation or precision. Use CO₂ when bleeding control and thermal remodeling are valuable; use Er:YAG when minimizing collateral heat and scarring is more important.

Start With the Lesion, Not the Device

Confirm that the lesion is appropriate for laser treatment

The lesion should have a confident benign diagnosis before ablation. Any lesion with atypical clinical features, diagnostic uncertainty, or suspected malignancy generally requires appropriate evaluation and, when indicated, biopsy rather than empiric laser destruction.

Laser treatment also does not eliminate the possibility of recurrence. Patients should understand that follow-up may be needed, particularly when the lesion extends into deeper tissue.

Assess vascularity and bleeding risk

Vascular or highly angiomatous lesions are more difficult to treat with a modality that provides little coagulation. Thick papules, angiofibromas, and hyperplastic formations such as rhinophyma may therefore favor CO₂ treatment.

Less vascular lesions can often be treated with Er:YAG when the main requirement is controlled superficial ablation rather than hemostasis.

Estimate lesion depth and thickness

Superficial lesions can often be removed accurately with Er:YAG because its high water absorption produces shallow ablation and a narrow zone of residual thermal damage.

Thicker lesions may require deeper ablation. CO₂ can be advantageous in these cases because it combines tissue vaporization with thermal coagulation and may achieve the desired result with fewer passes.

When CO₂ Is the Better Choice

Vascular or hyperplastic lesions

CO₂ lasers create a stronger thermal effect than Er:YAG systems. This produces coagulation during ablation, helping maintain a relatively bloodless field and improving visibility while sculpting the lesion.

This characteristic is particularly useful for vascular or hyperplastic tissue formations, including rhinophyma and bleeding-prone papules such as angiofibromas.

Deeper or thicker lesions

CO₂ is often favored when the target extends beyond the most superficial layers. Its thermal component supports deeper tissue treatment and can contribute to collagen contraction and remodeling.

The trade-off is greater peripheral thermal injury and a longer recovery period than with a more superficial Er:YAG approach.

When tissue contraction is beneficial

If treatment aims not only to remove the lesion but also to produce meaningful dermal thermal remodeling, CO₂ offers a stronger effect. This consideration is more relevant when treating substantial textural irregularity, deeper scarring, or associated photodamage than when removing a small superficial lesion.

When Er:YAG Is the Better Choice

Superficial, discrete lesions

Er:YAG provides highly precise ablation with minimal residual heat. This makes it useful for small or superficial benign lesions where the clinician wants to remove tissue without unnecessarily affecting adjacent skin.

It is also suitable when the lesion is less angiomatous and substantial bleeding is not expected.

Delicate facial procedures

The narrow thermal damage zone of Er:YAG can be valuable on cosmetically sensitive facial areas. For example, superficial facial osteoma cutis may be treated with Er:YAG ablation in combination with mechanical removal when limiting thermal spread and scar formation is critical.

Patients for whom recovery and pigmentary risk matter

Er:YAG generally produces less postoperative erythema and faster recovery than more thermally aggressive CO₂ treatment. Its reduced thermal injury may also be advantageous when the priority is limiting collateral damage and pigmentary complications, although patient skin type and treatment parameters still influence risk.

Match the Laser to the Treatment Objective

Removal versus remodeling

The primary goal may be lesion removal, hemostasis, surface precision, or dermal remodeling. These goals are related but not identical, so the same laser is not automatically optimal for every benign lesion.

Er:YAG emphasizes precise vaporization. CO₂ adds a broader thermal coagulation effect that can improve hemostasis and promote collagen contraction.

Ablation depth and settings matter

Laser type alone does not determine the outcome. Spot size, pulse duration, fluence, treatment mode, number of passes, and the operator’s assessment of tissue depth all affect clearance, thermal injury, and scarring risk.

Parameters should be adjusted to the lesion rather than transferred from resurfacing protocols or from a different lesion type.

Consider combination treatment when priorities conflict

Some lesions require both accurate ablation and bleeding control. In such situations, clinicians may use Er:YAG for precise superficial removal and CO₂ when deeper ablation or additional hemostasis is needed.

Combination treatment should be considered selectively. More energy or more modalities do not inherently produce a better result.

Understanding the Trade-offs

CO₂ offers hemostasis but increases thermal exposure

The principal advantage of CO₂ is also its main limitation: its thermal effect. Coagulation improves bleeding control and can support treatment of thicker tissue, but excess heat can increase postoperative erythema, delayed healing, pigmentary change, and scarring risk.

This is especially important on the face, where even a benign lesion may be less consequential than the scar left after treatment.

Er:YAG offers precision but limited coagulation

Er:YAG minimizes residual thermal damage, but it provides less hemostasis than CO₂. Bleeding can obscure the field and complicate treatment when the lesion is vascular or deeply rooted.

For this reason, Er:YAG may be less suitable as the sole modality for highly angiomatous or thick lesions.

Do not confuse ablative and non-ablative Erbium systems

“Erbium laser” can refer to different platforms. Er:YAG at approximately 2940 nm is an ablative system used for precise tissue vaporization, whereas Er:Glass systems around 1540/1550 nm are commonly non-ablative and primarily heat the dermis without removing the epidermis.

These systems should not be treated as interchangeable when selecting a device for physical removal of a benign lesion.

Avoid applying resurfacing evidence uncritically

Fractional CO₂ and non-ablative Er:Glass systems are often discussed in the context of scars, wrinkles, and photoaging. Those comparisons address collagen remodeling and downtime, not necessarily the best method for removing a discrete benign facial lesion.

For lesion treatment, vascularity, thickness, and the need for direct ablation remain the central selection criteria.

How to Apply This to Clinical Planning

A practical decision sequence is to confirm the diagnosis, estimate depth and vascularity, define the cosmetic endpoint, and then select the least aggressive modality capable of achieving that endpoint.

If your primary focus is hemostasis or treatment of a thick, vascular lesion: Favor a CO₂ system because its thermal coagulation supports bleeding control and deeper tissue ablation.
If your primary focus is precise superficial removal: Favor an ablative Er:YAG system because it limits peripheral thermal damage and allows controlled layer-by-layer ablation.
If your primary focus is minimizing scarring and downtime: Prefer Er:YAG when the lesion is superficial and non-vascular, while recognizing that inadequate hemostasis may limit its use.
If your primary focus is treating a lesion with both superficial and deeper components: Consider a tailored or combined approach, using precision ablation and adding CO₂-mediated coagulation only when clinically necessary.

The safest choice is the least thermally aggressive system that can reliably address the lesion’s depth and vascularity while meeting the patient’s cosmetic and recovery priorities.

Summary Table:

Feature	CO2 Laser	Er:YAG Laser
Primary Advantage	Strong coagulation and hemostasis	Precise ablation with minimal thermal damage
Best For	Vascular, thick, or hyperplastic lesions	Superficial, less vascular lesions
Tissue Interaction	More thermal effects, deeper ablation	Shallower ablation, narrower thermal zone
Bleeding Control	Excellent	Limited
Recovery	Longer, more erythema	Faster, less downtime
Scarring Risk	Higher if not careful	Lower
Examples	Rhinophyma, angiofibromas	Superficial facial lesions, delicate areas

Are you ready to enhance your practice with the right laser technology? At BELIS, we offer a comprehensive range of professional-grade medical aesthetic equipment, including advanced CO2 and Er:YAG laser systems designed for clinics and premium salons. Our experts can help you choose the ideal device for your specific clinical needs. Contact us today to learn more about our cutting-edge solutions and how we can support your success.